Maravai LifeSciences Holdings Inc expected to post earnings of 1 cent a share - Earnings Preview

Maravai Lifesciences Holdings

04/08/2023 23:01

* Maravai LifeSciences Holdings Inc  MRVI.OQ   MRVI.O  is
expected
to show a fall in quarterly revenue when it reports  results on
August 7. 
    * The San Diego California-based  company is expected to
report  a
70.7% decrease in revenue to $71.126 million from $242.73
million a year ago, according to the mean estimate from 11
analysts, based on Refinitiv data. The company's guidance on May
8 2023, for the period ended June 30, was for revenue of $70.000
million.
    * ​Refinitiv's mean analyst estimate for Maravai
LifeSciences
Holdings Inc is for earnings of 1 cent per share. 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 8 "strong buy" or "buy," 4
"hold" and no "sell" or "strong sell."  
    * The mean earnings estimate of analysts was unchanged in
the last
three months. ​
    * Wall Street's median 12-month price target for Maravai
LifeSciences Holdings Inc is $18​, above​ its last closing price
of $12.06. ​​​

Previous quarterly performance (using preferred earnings measure
in US dollars). ​
 QUARTER       STARMINESM  REFINITIV  ACTUAL    BEAT,   SURPRI
 ENDING        ARTESTIMAT  IBES                 MET,    SE %
               E®          ESTIMATE             MISSED  
 Mar. 31 2023  0.04        0.04       0.03      Missed  -17.2
 Dec. 31 2023  0.35        0.34       0.35      Beat    2.4
 Sep. 30 2022  0.33        0.33       0.37      Beat    12.2​
 Jun. 30 2022  0.45        0.45       0.54      Beat    18.8
 ​​Mar.        0.44        0.44       0.54      Beat    23
 31 2022                                                
 Dec. 31 2021  0.38        0.38       0.45      Beat    17.1​
 Sep. 30 2021  0.36        0.35       0.44      Beat    24.9
 Jun. 30 2021  0.32        0.32       0.44      Beat    39
 This summary was machine generated August 4 at 22:01 GMT.  All
figures in US dollars  unless otherwise stated